Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis

Journal of the American Society of Nephrology

Volumn 20, Issue 1, 2009, Pages 68-77

  Iyoda, Masayuki ^a,d   Hudkins, Kelly L ^a   Becker Herman, Shirly ^b,c   Wietecha, Tomasz A ^a   Banas, Miriam C ^e   Guo, Shunhua ^a   Meyer Bahlburg, Almut ^c   Kowalewska, Jolanta ^a   Liu, Gang ^a   Ziegler, Steven F ^c   Rawlings, David J ^b,c   Alpers, Charles E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULIN PRODUCTION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 58149496650     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008010036     Document Type: Article

References (35)

1. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A: A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 22: 321-328, 1994
2. Levin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM, Farr AG: Thymic stromal lymphopoietin: A cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol 162: 677-683, 1999
3. Ray RJ, Furlonger C, Williams DE, Paige CJ: Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol 26: 10-16, 1996
4. Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF: Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6: 1047-1053, 2005
5. Ziegler SF, Liu YJ: Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7: 709-714, 2006
6. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF: Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202: 541-549, 2005
7. Al-Shami A, Spolski R, Kelly J, Fry T, Schwartzberg PL, Pandey A, Mackall CL, Leonard WJ: A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med 200: 159-168, 2004
8. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001
9. Wong S, Witte ON: The BCR-ABL story: Bench to bedside and back. Annu Rev Immunol 22: 247-306, 2004
10. Druker BJ: Imatinib as a paradigm of targeted therapies. Adv Cancer Res 91: 1-30, 2004
11. Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ: PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59: 1324-1332, 2001
12. Lassila M, Jandeleit-Dahm K, Seah KK, Smith CM, Calkin AC, Allen TJ, Cooper ME: Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 16: 363-373, 2005
13. Savikko J, Taskinen E, Von Willebrand E: Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: Tyrosine kinase inhibitors as a potential therapy. Transplantation 75: 1147-1153, 2003
14. Zoja C, Corna D, Rottoli D, Zanchi C, Abbate M, Remuzzi G: Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease. Kidney Int 70: 97-103, 2006
15. Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M: Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice. Arthritis Rheum 52: 3987-3996, 2005
16. Wang S, Wilkes MC, Leof EB, Hirschberg R: Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 19: 1-11, 2005
17. Floege J, Eitner F, Van Roeyen C, Ostendorf T: PDGF-D and renal disease: Yet another one of those growth factors? J Am Soc Nephrol 14: 2690-2691, 2003
18. Hudkins KL, Gilbertson DG, Carling MD, S T, Hughes SD, Holdren MS, Palmer TE, Topouzis S, Haran AC, Feldhaus AL, Alpers CE: Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 15: 286-298, 2004
19. Iida H, Seifert R, Alpers CE, Gronwald RG, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, et al.: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A 88: 6560-6564, 1991
20. Johnson RJ, Floege J, Couser WG, Alpers CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4: 119-128, 1993
21. Taneda S, Hudkins KL, Cui Y, Farr AG, Alpers CE, Segerer S: Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 63: 576-590, 2003
22. Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP: Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65: 1165-1175, 1991
23. Hardin JD, Boast S, Schwartzberg PL, Lee G, Alt FW, Stall AM, Goff SP: Bone marrow B lymphocyte development in c-abl-deficient mice. Cell Immunol 165: 44-54, 1995
24. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC: Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153-1163, 1991
25. Hardin JD, Boast S, Schwartzberg PL, Lee G, Alt FW, Stall AM, Goff SP: Abnormal peripheral lymphocyte function in c-abl mutant mice. Cell Immunol 172: 100-107, 1996
26. Lam QL, Lo CK, Zheng BJ, Ko KH, Osmond DG, Wu GE, Rottapel R, Lu L: Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice. Int Immunol 19: 267-276, 2007
27. Rolink A, Streb M, Nishikawa S, Melchers F: The c-kit-encoded tyrosine kinase regulates the proliferation of early pre-B cells. Eur J Immunol 21: 2609-2612, 1991
28. Waskow C, Paul S, Haller C, Gassmann M, Rodewald HR: Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity 17: 277-288, 2002
29. Agosti V, Corbacioglu S, Ehlers I, Waskow C, Sommer G, Berrozpe G, Kissel H, Tucker CM, Manova K, Moore MA, Rodewald HR, Besmer P: Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J Exp Med 199: 867-878, 2004
30. Muhlfeld AS, Segerer S, Hudkins K, Carling MD, Wen M, Farr AG, Ravetch JV, Alpers CE: Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 163: 1127-1136, 2003
31. Kowalewska J, Muhlfeld AS, Hudkins KL, Yeh MM, Farr AG, Ravetch JV, Alpers CE: Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease. Am J Pathol 170: 981-989, 2007
32. Astrakhan A, Omori M, Nguyen T, Becker-Herman S, Iseki M, Aye T, Hudkins K, Dooley J, Farr A, Alpers CE, Ziegler SF, Rawlings DJ: Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development. Nat Immunol 8: 522-531, 2007
33. Paniagua RT, Sharpe O, Ho PP, Chan SM, Chang A, Higgins JP, Tomooka BH, Thomas FM, Song JJ, Goodman SB, Lee DM, Genovese MC, Utz PJ, Steinman L, Robinson WH: Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest 116: 2633-2642, 2006
34. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964, 2005
35. Muhlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE: Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int 65: 1214-1223, 2004